Saturday 17 October 2026
Export LMAT’s income statement to Excel — free account
LeMaitre Vascular, Inc.
LMAT Healthcare Medical Instruments & Supplies
LeMaitre Vascular, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $249.6 million, up 13.5% from fiscal 2024. In the quarter to June 2026, revenue grew 9.57%, EPS grew 23.0%, free cash flow fell 28.0% and total debt was flat, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.
80.82
2.34
−2.81%
Follow LMAT
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
44.26 | 34.58 | 20.03 | 39.94 | 38.57 | 39.55 | 47.82 | 42.01 | 46.77 | 31.68 |
Piotroski F-Score |
8 | 6 | 4 | 2 | 3 | 7 | 4 | 8 | 6 | 6 |
Altman Z-Score |
21.67 | 24.18 | 14.36 | 12.50 | 7.74 | 18.34 | 16.13 | 17.42 | 7.67 | 6.99 |
P/S ratio |
5.23 | 5.85 | 4.35 | 6.08 | 6.34 | 6.88 | 6.18 | 6.51 | 9.41 | 7.36 |
P/FCF ratio |
33.24 | 35.92 | 27.96 | 68.53 | 24.25 | 35.20 | 43.44 | 42.77 | 55.71 | 24.66 |
Altman Z″-Score (non-manufacturers) |
11.06 | 12.30 | 11.38 | 8.09 | 5.73 | 11.37 | 11.15 | 11.31 | 7.56 | 8.18 |
Beneish M-Score |
(2.55) | (2.62) | (2.36) | (2.28) | (2.53) | (2.50) | (2.49) | (2.36) | (3.52) | (2.61) |
P/Operating CF |
111.20 | 87.16 | 69.89 | 127.33 | 57.94 | 210.19 | 244.87 | 117.25 | 136.26 | 79.28 |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 93 |
P/B ratio |
5.33 | 5.38 | 3.53 | 4.81 | 4.75 | 4.18 | 3.72 | 4.23 | 6.13 | 4.67 |
Price to Tangible BV |
8.61 | 7.59 | 5.30 | 8.55 | 17.18 | 7.84 | 6.41 | 6.62 | 8.78 | 6.23 |
EV/Sales |
4.96 | 5.44 | 3.90 | 5.93 | 6.42 | 6.54 | 5.77 | 6.06 | 8.82 | 6.60 |
EV/EBITDA |
22.19 | 21.80 | 12.64 | 26.14 | 22.35 | 21.26 | 25.74 | 25.35 | 31.32 | 20.81 |
EV/Operating CF |
26.17 | 23.98 | 21.08 | 49.04 | 23.88 | 28.77 | 36.78 | 31.89 | 43.96 | 20.29 |
EV/FCF |
31.51 | 33.39 | 25.03 | 66.90 | 24.57 | 33.44 | 40.61 | 39.78 | 52.23 | 22.14 |
Quick Ratio |
3.58 | 4.30 | 3.22 | 2.36 | 1.85 | 4.11 | 4.13 | 4.36 | 10.77 | 10.81 |
Current Ratio |
5.63 | 6.09 | 4.76 | 4.42 | 3.75 | 6.41 | 6.39 | 6.51 | 13.14 | 12.89 |
Net Debt/EBITDA |
(1.22) | (1.66) | (1.47) | (0.64) | 0.30 | (1.18) | (1.87) | (2.27) | (2.13) | (2.40) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 8.34% | 15.04% | 4.80% | 4.74% | 0.00% | 30.40% | 27.39% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.11 | 0.22 | 0.06 | 0.05 | 0.00 | 0.50 | 0.43 |
Asset Turnover |
0.93 | 0.88 | 0.76 | 0.69 | 0.59 | 0.57 | 0.54 | 0.59 | 0.49 | 0.43 |
Operating CF/Net income |
1.60 | 1.33 | 0.85 | 0.79 | 1.64 | 1.30 | 1.23 | 1.22 | 1.00 | 1.41 |
Capex/Depreciation |
(0.79) | (1.58) | (0.71) | (0.69) | (0.11) | (0.44) | (0.25) | (0.76) | (0.72) | (0.60) |
Interest Coverage |
1,166.86 | 1,004.90 | 14,104.50 | — | 21.98 | 16.42 | — | — | 254.91 | 13.10 |
| 12.81% | 17.41% | 19.12% | 12.88% | 13.23% | 12.61% | 7.90% | 10.64% | 13.87% | 15.80% | |
| 11.00% | 15.05% | 16.42% | 10.51% | 9.62% | 9.86% | 6.84% | 9.16% | 9.80% | 9.89% | |
ROIC |
16.15% | 19.36% | 21.44% | 10.09% | 9.80% | 11.48% | 8.37% | 11.90% | 15.91% | 20.90% |
Return on Tangible Assets |
18.72% | 21.61% | 25.97% | 20.83% | 25.22% | 19.91% | 13.37% | 16.14% | 11.11% | 12.58% |
Average Days of Receivables |
54.01 | 54.28 | 54.36 | 51.60 | 55.17 | 46.40 | 49.77 | 47.28 | 49.91 | 49.15 |
Research and Development Expense of Revenue |
6.89% | 6.58% | 7.76% | 7.91% | 7.81% | 7.64% | 8.22% | 8.77% | 7.12% | 5.66% |
Selling, General and Administrative Expense of Revenue |
45.38% | 42.59% | 42.63% | 42.13% | 35.71% | 34.42% | 38.15% | 37.67% | 37.75% | 38.66% |
Intangible Assets out of Total Assets |
0.33 | 0.25 | 0.28 | 0.34 | 0.49 | 0.41 | 0.36 | 0.31 | 0.18 | 0.16 |
Share Based Compensation of Revenue |
1.88% | 2.24% | 2.23% | 2.25% | 2.34% | 2.25% | 2.58% | 2.75% | 2.99% | 3.14% |
Graham Net Nets |
0.10 | 0.11 | 0.16 | 0.07 | 0.02 | 0.10 | 0.12 | 0.12 | 0.09 | 0.13 |
Graham Number |
7.79 | 10.83 | 13.34 | 12.30 | 14.19 | 18.53 | 16.15 | 20.18 | 25.80 | 31.64 |
Earnings Yield |
2.26% | 2.89% | 4.99% | 2.50% | 2.59% | 2.53% | 2.09% | 2.38% | 2.14% | 3.16% |
Free Cash Flow Yield |
3.01% | 2.78% | 3.58% | 1.46% | 4.12% | 2.84% | 2.30% | 2.34% | 1.80% | 4.05% |
Revenue per Share |
4.82 | 5.32 | 5.43 | 5.92 | 6.39 | 7.30 | 7.36 | 8.71 | 9.79 | 11.03 |
Operating CF per Share |
0.91 | 1.21 | 1.00 | 0.72 | 1.72 | 1.66 | 1.15 | 1.65 | 1.97 | 3.59 |
Capex per Share |
(0.15) | (0.34) | (0.16) | (0.19) | (0.05) | (0.23) | (0.11) | (0.33) | (0.31) | (0.30) |
Free Cash Flow per Share |
0.76 | 0.87 | 0.85 | 0.53 | 1.67 | 1.43 | 1.05 | 1.33 | 1.66 | 3.29 |
Cash per Share |
1.31 | 2.20 | 2.47 | 1.65 | 1.33 | 3.31 | 3.76 | 4.73 | 13.35 | 15.86 |
Shareholders Equity per Share |
4.73 | 5.79 | 6.70 | 7.48 | 8.52 | 12.01 | 12.20 | 13.41 | 15.02 | 17.38 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
4.73 | 5.79 | 6.70 | 7.48 | 8.52 | 12.01 | 12.20 | 13.41 | 15.02 | 17.38 |
Free Cash Flow |
14.05 | 16.45 | 16.45 | 10.42 | 33.84 | 30.22 | 23.01 | 29.49 | 37.16 | 74.47 |
Working Capital |
48.55 | 67.12 | 74.26 | 71.24 | 69.12 | 118.07 | 136.40 | 164.72 | 371.59 | 431.91 |
Capital Expenditures |
(2.84) | (6.42) | (3.05) | (3.76) | (0.96) | (4.88) | (2.37) | (7.26) | (6.96) | (6.78) |
Net Current Asset Value |
44.60 | 63.76 | 71.16 | 51.89 | 14.03 | 101.23 | 119.46 | 145.72 | 187.67 | 246.06 |
EV/EBIT |
27.06 | 25.99 | 14.58 | 32.82 | 28.87 | 27.72 | 34.79 | 31.92 | 37.12 | 24.27 |
Capex to Sales |
0.03 | 0.06 | 0.03 | 0.03 | 0.01 | 0.03 | 0.01 | 0.04 | 0.03 | 0.03 |
Price to Operating Income |
28.55 | 27.96 | 16.28 | 33.63 | 28.48 | 29.18 | 37.21 | 34.32 | 39.59 | 27.03 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.45 | 0.33 | 0.31 | 0.36 | 0.56 | 0.65 | 0.53 | 0.44 | 0.39 | 0.42 |
Cash ROIC |
12.57% | 10.86% | 9.23% | 5.30% | 14.24% | 8.94% | 6.29% | 7.32% | 4.62% | 8.08% |
Accounts Receivable Turnover |
7.09 | 7.16 | 6.87 | 7.26 | 7.16 | 7.88 | 7.76 | 8.22 | 7.98 | 7.84 |
Accounts Payable Turnover |
20.30 | 21.86 | 19.32 | 17.24 | 17.91 | 22.41 | 21.65 | 20.02 | 25.10 | 26.29 |
Inventory Turnover |
1.51 | 1.49 | 1.31 | 1.12 | 1.06 | 1.16 | 1.18 | 1.23 | 1.12 | 1.05 |
Average Days of Payables |
16.94 | 18.67 | 19.99 | 25.43 | 19.53 | 16.10 | 18.67 | 20.51 | 9.32 | 18.73 |
Days of Inventory on Hand |
272.59 | 254.62 | 316.06 | 385.97 | 367.99 | 317.26 | 323.30 | 319.10 | 343.64 | 361.71 |
Average Receivables |
12.58 | 14.10 | 15.36 | 16.15 | 18.06 | 19.59 | 20.84 | 23.55 | 27.56 | 31.84 |
Average Payables |
1.29 | 1.38 | 1.64 | 2.17 | 2.50 | 2.37 | 2.62 | 3.32 | 2.75 | 2.70 |
Average Inventory |
17.39 | 20.31 | 24.22 | 33.46 | 42.32 | 45.61 | 48.19 | 54.18 | 61.50 | 67.67 |
Average Assets |
96.31 | 114.12 | 139.71 | 170.71 | 220.58 | 272.81 | 301.64 | 328.63 | 449.30 | 583.75 |
Average Common Equity |
82.69 | 98.64 | 120.00 | 139.19 | 160.36 | 213.36 | 261.18 | 283.05 | 317.60 | 365.40 |
Columns are period end dates